Neuroprotective compounds inhibit depolarisation-evoked calcium transients in granule cells

Drug Development Research

Volumn 45, Issue 2, 1998, Pages 74-82

  Hubert, Jean Pierre ^a  

^a SANOFI   (France)

Author keywords

Anticonvulsant; Granule cell; Indo 1 AM; Intracellular calcium; Neuroprotectant; NMDA; Primary culture; Veratridine

Indexed keywords

ANTICONVULSIVE AGENT; APTIGANEL; CALCIUM CHANNEL; FELBAMATE; GABAPENTIN; LAMOTRIGINE; LUBELUZOLE; N METHYL DEXTRO ASPARTIC ACID; NEUROPROTECTIVE AGENT; POTASSIUM CHLORIDE; RILUZOLE; RP 66055A; SIPATRIGINE; SODIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG; VERATRIDINE; XALIPRODEN;

ANIMAL CELL; ANTICONVULSANT ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM MOBILIZATION; DEPOLARIZATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SELECTIVITY; GRANULE CELL; NEUROPROTECTION; NEWBORN; NONHUMAN; RAT;

EID: 0032423270     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199810)45:2<74::AID-DDR4>3.0.CO;2-H     Document Type: Article

References (13)

1. IA receptor agonist. Fundam Clin Pharmacol 7:487-497.
2. Bensimon G, Lacomblez L, Meininger V, the ALS/Riluzole study group. 1994. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330:585-591.
3. Bryson H, Fulton B, Benfield P. 1996. Riluzole: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis. Drugs 52:549-563.
4. Cheung H, Kamp D, Harris E. 1992. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 13:107-112.
5. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
6. Diener HC, Hacke W, Hennerici M, Rådberg J, Hantson L, De Keyser J, for the Lubeluzole International Study Group. 1996. Lubeluzole in ischaemic stroke: a double-blind, placebo-controlled phase II trial. Stroke 27:76-81.
7. Doble A. 1996. The pharmacology and mechanism of action of riluzole. Neurology 47(Suppl 4):S233-S241.
8. Fournier J, Steinberg R, Gauthier T, Keane PE, Guzzi U, Coude FX, Bougault I, Maffrand JP, Soubrié P, Le Fur G. 1993. Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates. Neuroscience 55:629-641.
9. Gallo V, Ciotti MT, Coletti A, Alosi F, Levy G. 1982. Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc Natl Acad Sci USA 79:7919-7923.
10. 2δ subunit of a calcium channel. J Biol Chem 271:5768-5776.
11. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
12. Gurney ME, Cutting FB, Zhai P, Doble A, Taylor CP, Andrus PK, Hall ED. 1996. Benefit of vitamin E, riluzole and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 39:147-157.
13. Hough CJ, Irwin RP, Gao XM, Rogawski MA, Chuang DM. 1996. Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells. J Pharmacol Exp Ther 276:143-149.